Bringing antivenoms to Sub-Saharan Africa.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 17287747.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To reduce unacceptably high death rates from snakebite envenomation, sub-Saharan Africa must adopt not only a new generation of multivalent biotech antivenoms, but also an infrastructure to deliver them.
Medical subject headings
- Antivenins
- Delivery of Health Care
- Health Policy
- Rural Health
- Snake Bites